Hepatitis C Support Group

Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.

426 Members
21,304 Posts
0 Online
Gastrointestinal System
/ Hepatitis C Support Group

HELIX-2 - Samatasvir - all oral Ph II trial

ImKramer
ImKramer
US-based biopharmaceutical company Idenix Pharmaceuticals has started patient enrollment in the Phase II HELIX-2 clinical trial evaluating an all-oral, direct-acting antiviral (DAA) HCV combination therapy of samatasvir, simeprevir and TMC647055 for the treatment of hepatitis c virus (HCV) infection.

http://clinicaltrials.pharmaceutical-business-review.com/news/idenix-pharma-begins-phase-ii-combination-trial-to-treat-hepatitis-c-virus-infection-031213-4139779
MLTTexas
MLTTexas
How do we find out where this trial is taking place?
ImKramer
ImKramer
Marilyn here is the website:
http://www.idenix.com/
Clinical trials here:
http://www.clinicaltrials.gov/ct2/home
I could not find Samatasvir listed at the clinical trial site.
I think it might be in Europe
http://www.medivir.se/v5/en/uptodate/pressrelease.cfm?releaseid=06B69C8F55BEBDD5&year=2013